Top segments and regional performance

Last year, the company generated ‪13.37 B‬ USD, the most of which — ‪12.78 B‬ USD — came from its top-performing segment, Medical Drugs, compared to ‪11.98 B‬ USD the previous year. The greatest contribution came from United States, which accounted for ‪4.72 B‬ USD last year, with ‪4.28 B‬ USD the year before.